How do updated moa/target annotations influence moa/target recall?

[gwaybio]

A potentially fun analysis would be to evaluate how the different moa/target annotations updated over time (in different CLUE drugs/samples versions) influence moa/target recall.

Essentially, we would setup an eval framework (I imagine there is a traditional moa/target recall eval) where we use the same input profiles and alter the moa/target information as they have been updated over time.

If we see improvement over time this tells us that annotations are improving and, potentially, that there is even more room to improve categorization.